Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Philippines Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Philippines pharmaceutical industry is emerging as one of the ASEAN region's potentially attractive markets owing to its growing population, financial prospects, government initiatives, increasing acceptance of generic medicines, improving patient access and care, disease prevention, and management programs, among others. The Philippines pharmaceutical market, in terms of US dollars, was valued at $3.0 billion in 2011, which increased to $3.2 billion in 2017 at a Compound Annual Growth Rate (CAGR) of 1.5%. The market value is expected to grow further and is forecast to reach $3.7 billion by 2026. The Philippines medical device market, largely driven by imports, is forecast to increase at a CAGR of 8.8% from 2021 to reach $884 million in 2023.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, and includes -

• - An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• - Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Boehringer Ingelheim, Astellas, and Unilab.
• - Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Medtronic, Philips, GE Healthcare, and Siemens Healthineers.
• - An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• - Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• - An overview of the opportunities for and challenges to growth in the Philippines healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Philippines healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Philippines healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership